Quest Diagnostics' (DGX) New Buyout Ramps Up Cancer Diagnosis
Yahoo Finance · 19 hours ago
Open | 136.33 |
High | 137.75 |
Low | 136.33 |
Mkt Cap | 15.25B |
P/E (TTM) | 18.48 |
Div & Yield | 3.00 & 2.18% |
Prev. Close | 137.02 |
52 Wk. Low | 119.59 |
52 Wk. High | 145.62 |
Related stocks
Medical research company
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 2.37B | 1.50% ▲ |
Net Income | 194M | 4.00% ▼ |
Diluted EPS | 2.04 | 3.40% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $2.33 | - |
Q1 2024 | $1.85 | $2.04 |
Q4 2023 | $2.11 | $2.15 |
S&P 500^GSPC | 5,487.03+13.80 (+0.25%) |
Dow 30^DJI | 38,834.86+56.76 (+0.15%) |
Nasdaq^IXIC | 17,862.23+5.21 (+0.03%) |
135.58+3.51% | |
31.31-9.82% | |
174.13+8.63% |